Angiotensin II Type 1 Receptor Blockers: all 909 studies that test it
Page 10 of 10. Open to participants first (60), then studies with results posted, then the rest; newest registration first within each.
- Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial FibrillationCompletedNCT00098137Phase 3
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate HypertensionCompletedNCT00095550Phase 3
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionCompletedNCT00095394Phase 3
- Irbesartan Versus Placebo in Combination With Ramipril for Treatment of AlbuminuriaCompletedNCT00095290Phase 4
- Optimal Treatment for Kidney Disease in HIV Infected AdultsWithdrawnNCT00089518Phase 3
- Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed DoseCompletedNCT00034840Phase 4
- Study of Inherited Changes of Receptors Located on Blood VesselsCompletedNCT00001741Phase 1
- The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular FunctionCompletedNCT00001629Phase 3
- The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular FunctionCompletedNCT00001628Phase 3